Michael F. Egan

Overview

Best Publications

• Serotonin Transporter Genetic Variation and the Response of the Human Amygdala

  Ahmad R. Hariri;Venkata S. Mattay;Alessandro Tessitore;Bhaskar Kolachana

  2984
  Citations

• 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression

  Lukas Pezawas;Andreas Meyer-Lindenberg;Emily M Drabant;Beth A Verchinski

  2445
  Citations

• Functional Analysis of Genetic Variation in Catechol-O-Methyltransferase (COMT): Effects on mRNA, Protein, and Enzyme Activity in Postmortem Human Brain

  Jingshan Chen;Barbara K. Lipska;Nader Halim;Quang D. Ma

  2072
  Citations

• Brain-Derived Neurotrophic Factor val66met Polymorphism Affects Human Memory-Related Hippocampal Activity and Predicts Memory Performance

  Ahmad R. Hariri;Terry E. Goldberg;Venkata S. Mattay;Bhaskar S. Kolachana

  1262
  Citations

• Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

  Venkata S. Mattay;Terry E. Goldberg;Francesco Fera;Ahmad R. Hariri

  1158
  Citations

• The Brain-Derived Neurotrophic Factor val66met Polymorphism and Variation in Human Cortical Morphology

  Lukas Pezawas;Beth A. Verchinski;Venkata S. Mattay;Joseph H. Callicott

  1077
  Citations

• A Susceptibility Gene for Affective Disorders and the Response of the Human Amygdala

  Ahmad R. Hariri;Emily M. Drabant;Karen E. Munoz;Bhaskar S. Kolachana

  1063
  Citations

• Prefrontal neurons and the genetics of schizophrenia.

  Daniel R. Weinberger;Michael F. Egan;Alessandro Bertolino;Joseph H. Callicott

  925
  Citations

• Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down.

  Joseph H. Callicott;Venkata S. Mattay;Beth A. Verchinski;Stefano Marenco

  856
  Citations

• Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.

  Terry E. Goldberg;Michael F. Egan;Tonya Gscheidle;Richard Coppola

  780
  Citations

• Evidence for abnormal cortical functional connectivity during working memory in schizophrenia.

  Andreas Meyer-Lindenberg;Jean-Baptiste Poline;Philip D. Kohn;John L. Holt

  690
  Citations

• Cognitive Impairments in Patients With Schizophrenia Displaying Preserved and Compromised Intellect

  Thomas W. Weickert;Terry E. Goldberg;James M. Gold;Llewellen B. Bigelow

  683
  Citations

• Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia.

  Andreas S. Meyer-Lindenberg;Rosanna K. Olsen;Philip D. Kohn;Timothy Brown

  678
  Citations

• Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease

  Michael F. Egan;James Kost;Pierre N. Tariot;Paul S. Aisen

  650
  Citations

• Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia

  Joseph H. Callicott;Richard E. Straub;Lukas Pezawas;Michael F. Egan

  631
  Citations

• Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia.

  Joseph H. Callicott;Michael F. Egan;Venkata S. Mattay;Alessandro Bertolino

  555
  Citations

• Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease

  Michael F. Egan;James Kost;Tiffini Voss;Yuki Mukai

  537
  Citations

• Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.

  Michael F. Egan;Richard E. Straub;Terry E. Goldberg;Imtiaz Yakub

  517
  Citations

• The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients

  Matthew E. Kennedy;Andrew W. Stamford;Xia Chen;Kathleen Cox

  464
  Citations

• Comparison of Ketamine-Induced Thought Disorder in Healthy Volunteers and Thought Disorder in Schizophrenia

  Caleb M. Adler;Anil K. Malhotra;Igor Elman;Terry Goldberg

  420
  Citations